Technologies by Gabriel Kwong
Antigen-specific Cell Programming Using non-viral Approaches

T cell therapies can be costly and carry serious risks

8703
Scarless isolation of antigen-specific T cells for CAR T cell manufacturing via DNA-gated sorting

CAR T cell therapies are often limited in effectiveness against solid tumors

9388
Activity-based synthetic liquid biopsy of solid tumors

Methods for monitoring tumors can be invasive and ineffective

9387
A Biological Computing Framework for Living Systems
Providing a foundation for programmable medicine
8009
Heat-Responsive Programmable T-Cells
Increasing oncological patients’ precision medicine with engineered T-cell therapies that contain heat-responsive biocircuitry
7422
Self-Titrating Bacterial Protease-Activated Prodrug
A new strategy to reduce antibiotic-resistant bacteria
8010